BioGeneration Ventures — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Kivu Biosciencekivubioscience.cominOct 2024 · $92M
Kivu Bioscience is a biotechnology company developing next-generation antibody-drug conjugates (ADCs) for oncology, using site-specific conjugation technology to create more stable and homogeneous cancer therapies with reduced off-tumor toxicity.
BiotechDeep TechHealthtech
Mohit Trikha(CEO)
Co-investorsBOMHealthCapM VenturesRed Tree VentureNovo Holdings
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.